GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 14, 2024
Displaying entries 6651 - 6700 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
7PJR Q6P988 Notum_ARUK3000438
7PK3 Q6P988 Notum_ARUK3001185
7PKV Q6P988 Notum_Inhibitor ARUK3000223
2NXY Q6P5S8 HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b
2NXZ Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY0 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b
2NY1 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b
2NY2 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b
2NY3 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY4 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY5 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b
2NY6 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b
6AL5 Q6P5S8 COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
6AL5 Q6P5S8 COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6WM3 Q6P5S7 Human V-ATPase in state 2 with SidK and ADP V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, V-type proton ATPase subunit D, V-type proton ATPase subunit F
6WLW Q6P5S7 The Vo region of human V-ATPase in state 1 (focused refinement) V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-)
7U4T Q6P5S7 Human V-ATPase in state 2 with SidK and mEAK-7
6WM2 Q6P5S7 Human V-ATPase in state 1 with SidK and ADP V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, k, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1
6WM4 Q6P5S7 Human V-ATPase in state 3 with SidK and ADP V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, SidK, V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H
7UNF Q6P5S7 CryoEM structure of a mEAK7 bound human V-ATPase complex
7RTW Q6P5F7 Cryo-EM structure of a TTYH3 cis-dimer
9B8O Q6P503 Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo
9BRD Q6P503 Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3
5WKI Q6P4G7 Crystal structure of PG90 TCR-CD1b-PG complex T-cell surface glycoprotein CD1b, Beta-2-microglobulin, T-cell receptor alpha variable 26-1,TRA@ protein, PG90 TCR beta chain
6EA4 Q6P179 ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitor
3SE6 Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 Endoplasmic reticulum aminopeptidase 2 (E.C.3.4.11.-)
4E36 Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392K
4JBS Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PSEUDOTRIPEPTIDE inhibitor.
5AB0 Q6P179 Crystal structure of aminopeptidase ERAP2 with ligand
5AB2 Q6P179 Crystal structure of aminopeptidase ERAP2 with ligand
5CU5 Q6P179 Crystal structure of ERAP2 without catalytic Zn(II) atom
5J6S Q6P179 Crystal structure of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in complex with a hydroxamic derivative ligand
5K1V Q6P179 Crystal structure of Endoplasmic Reticulum aminopeptidase 2 (ERAP2) in complex with a diaminobenzoic acid derivative ligand.
7P7P Q6P179 Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide((1R)-1-Amino-3-phenylpropyl){(2S)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino]-2-{[3-(2-hydroxyphenyl)-isoxazol-5-yl]methyl}-3-oxopropyl}phosphinic acid
7PFS Q6P179 Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide ((1R)-1-Amino-3-phenylpropyl){2-([1,1:3,1-terphenyl]-5-ylmethyl)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)-amino]-3-oxopropyl}phosphinic acid
7NSK Q6P179 Endoplasmic reticulum aminopeptidase 2 complexed with a hydroxamic ligand
7NUP Q6P179 Endoplasmic reticulum aminopeptidase 2 complexed with a mixed hydroxamic and sulfonyl ligand
5WZY Q6NYR1 Crystal structure of the P2X4 receptor from zebrafish in the presence of CTP at 2.8 Angstroms p2X purinoceptor
3H9V Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.1 Angstroms
3I5D Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.5 Angstroms (R3)
4DW0 Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 2.9 Angstroms P2X purinoceptor
4DW1 Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the ATP-bound, open state at 2.8 Angstroms P2X purinoceptor
8JV5 Q6NYR1 Cryo-EM structure of the zebrafish P2X4 receptor in complex with BX430
8JV6 Q6NYR1 Cryo-EM structure of the zebrafish P2X4 receptor in complex with BAY-1797
7NDG Q6NW40 Cryo-EM structure of the ternary complex between Netrin-1, Neogenin and Repulsive Guidance Molecule B Netrin-1, Neogenin, Repulsive Guidance Molecule B
7NE0 Q6NW40 Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin
7NE0 Q6NW40 Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin
6Z3J Q6NW40 Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) (crystal form 1)

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024